Katie Wright, Author at European Medical Journal - Page 26 of 45

Poor Sleep Quality Linked to Severe PMS Symptoms in Young Women

New research suggests that poor sleep quality worsens PMS symptoms, with nearly 50% of participants experiencing severe symptoms. The study highlights the crucial role of sleep in PMS management, suggesting that better sleep could help reduce mood swings, fatigue, and anxiety.

Link Between Tumour-Infiltrating Lymphocytes and Breast Cancer Survival

Study finds tumour-infiltrating lymphocytes linked to survival in early ERBB2-positive breast cancer, suggesting treatment de-escalation may be possible

Gut Microbiota Maturation Disrupted in Infants with Cystic Fibrosis

Findings revealed that microbiota maturation in cystic fibrosis is delayed, preventing the establishment of a stable, adult-like community.

Non-Invasive Markers Could Differentiate Complicated Appendicitis Early

Researchers have identified key biomarkers that could help distinguish between uncomplicated and complicated appendicitis, allowing for earlier and more accurate diagnosis. The study found that Red Cell Distribution Width (RDW), Mean Platelet Volume (MPV), and appendix diameter are reliable indicators of appendicitis severity.

New Study Uncovers Key Mechanisms in Psoriasis

Recent findings indicate that c-Rel expression is upregulated in psoriatic skin lesions and decreases following treatment.

New Approach Expands Surgical Options for Patients with Liver Cancer and Cirrhosis

Immunotherapy, targeted radiation, and a refined surgical technique allowed tumour removal in a liver cancer patient previously ineligible for surgery.

Tirzepatide Lowers Left Ventricular Mass and Fat in Obesity-Related HFpEF

Tirzepatide reduces LV mass and paracardiac fat in obesity-related HFpEF, offering structural heart benefits beyond weight loss.

Wearable Device Reduces Fatigue and Raynaud Symptoms in Systemic Sclerosis

A wearable device reduced fatigue and Raynaud symptoms in systemic sclerosis, improving quality of life without adverse effects.

Predicting Methotrexate Failure in Ectopic Pregnancy

A new retrospective study has identified key risk factors for methotrexate (MTX) treatment failure in tubal ectopic pregnancy (TEP). The findings suggest that higher gravidity and elevated β-hCG levels increase the likelihood of treatment failure, while additional MTX doses improve success rates.

Scientists Identify Genetic Variants That Drive Cancer Risk and Growth

Researchers uncover genetic variants that drive cancer risk, revealing new therapeutic targets and refining genetic screening strategies.